Not applicableStudy completedNCT01762449What this trial is testingMorbidity and Mortality Follow Up for the Scleroderma Lung StudyWho this might be right forScleroderma Duke University 158
Large-scale testing (Phase 3)Study completedNCT06758947What this trial is testingUse of Selective JAK Inhibitor in ILD and Skin Tightness of Systemic Sclerosis Versus MMFWho this might be right forInterstitial Lung Disease Due to Systemic Disease (Disorder) Assiut University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06947460What this trial is testingCD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAHWho this might be right forRefractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension Beijing GoBroad Hospital 45
Not applicableUnknownNCT00617487What this trial is testingPulmonary Arterial Hypertension in Systemic SclerosisWho this might be right forSystemic SclerosisPulmonary Arterial Hypertension Fondazione IRCCS Policlinico San Matteo di Pavia 200
Not applicableUnknownNCT06105073What this trial is testing"Pulmonary Rehabilitation Program in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis"Who this might be right forSystemic Sclerosis Associated Interstitial Lung Disease Coordinación de Investigación en Salud, Mexico 67
Early research (Phase 1)Study completedNCT02426229What this trial is testingSafety & Suitability of Dabigatran to Inhibit Thrombin in SclerodermaWho this might be right forSclerodermaInterstitial Lung Disease Medical University of South Carolina 15
Not applicableWithdrawnNCT01202045What this trial is testingStress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis PatientsWho this might be right forScleroderma, SystemicHypertension, Pulmonary Paul Farand
Not applicableLooking for participantsNCT05345795What this trial is testingInterstitial Lung Disease Trajectories in Patients With Systemic SclerosisWho this might be right forSystemic SclerosisInterstitial Lung Disease Central Hospital, Nancy, France 600
Large-scale testing (Phase 3)Study completedNCT00984932What this trial is testingEffect of Rosuvastatin on Systemic Sclerosis-related Pulmonary HypertensionWho this might be right forSystemic Sclerosis University of Alexandria 40
Not applicableNot Yet RecruitingNCT06579651What this trial is testingNailfold Capillaroscopic Pattern Changes and Its Correlation with Interstitial Lung Disease (ILD) in Systemic Sclerosis (SSc) Patients.Who this might be right forSystemic Sclerosis (SSc) Assiut University 45
Not applicableStudy completedNCT00377949What this trial is testingMulti-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma PatientsWho this might be right forSystemic SclerosisSclerodermaPulmonary Hypertension+1 more Georgetown University 602
Not applicableWithdrawnNCT05177471What this trial is testingEfficacy and Safety of JAK Inhibitors in Systemic Sclerosis-associated Interstitial Lung DiseaseWho this might be right forSystemic SclerosisInterstitial Lung Disease Central Hospital, Nancy, France
Not applicableUnknownNCT04650659What this trial is testingFunctional Exercise Tests in Patients With Systemic SclerosisWho this might be right forScleroderma, SystemicLung Diseases, InterstitialPulmonary Arterial Hypertension+1 more University of Aarhus 83
Not applicableLooking for participantsNCT07236970What this trial is testingMulticenter Study on the Development of Pulmonary Arterial Hypertension Screening Models Based on Artificial Intelligence for Patients With Systemic SclerosisWho this might be right forPulmonary HypertensionSystemic Sclerosis (SSc)Systemic Sclerosis-Associated PAH Alejandro Cruz Utrilla 350
Not applicableStudy completedNCT04118725What this trial is testingMuscular Respiratory Involvement and Systemic SclerosisWho this might be right forSystemic SclerosisDiaphragm DefectRespiratory Insufficiency+3 more Poitiers University Hospital 52
Post-approval studies (Phase 4)Not Yet RecruitingNCT07087912What this trial is testingSafety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic DiseasesWho this might be right forRheumatoid Arthritis (RA)Juvenile Idiopathic Arthritis (JIA)Systemic Lupus Erythematosus (SLE)+9 more University of Sao Paulo General Hospital 477
Not applicableUnknownNCT05455437What this trial is testingMonitoring and Evaluation Study of Project ECHO for ILDWho this might be right forInterstitial Lung Diseases Pulmonary Care and Research Collaborative Limited 200
Not applicableStudy completedNCT00909337What this trial is testingEarly Therapy of Pulmonary Arterial HypertensionWho this might be right forPulmonary HypertensionSystemic Sclerosis Medical University of Graz 10
Testing effectiveness (Phase 2)Ended earlyNCT01559129What this trial is testingStudy of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung DiseaseWho this might be right forScleroderma, SystemicSclerosis, SystemicSystemic Scleroderma+2 more Celgene 23
Early research (Phase 1)Ended earlyNCT04948554What this trial is testingMK-2225 / ACE-1334 in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease (MK-2225-002)Who this might be right forSystemic Sclerosis With and Without Interstitial Lung Disease Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 5